z-logo
open-access-imgOpen Access
Evaluating the addition of a platinum agent to a taxane in metastatic breast cancer and the benefits for TNBC. A Romanian centre experience
Author(s) -
Silvia Moşoiu,
Laurenţia Galeş,
Denisa Ciochir
Publication year - 2021
Publication title -
oncolog-hematolog ro
Language(s) - English
Resource type - Journals
eISSN - 2066-8716
pISSN - 2066-8260
DOI - 10.26416/onhe.5.1.2021.4569
Subject(s) - carboplatin , taxane , triple negative breast cancer , medicine , oncology , breast cancer , paclitaxel , metastatic breast cancer , docetaxel , triple negative , cancer , chemotherapy , cisplatin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom